Enanta Pharmaceuticals (9EP) Revenue
Enanta Pharmaceuticals Revenue
Enanta Pharmaceuticals had a revenue of 14.36M in the quarter ending Jun 30, 2026, with -16.32%. This bring the company's revenue in the last twelve months to 65.26M, Decreased 5.71%. In the fiscal year ending Sep 30, 2025, Enanta Pharmaceuticals had annual revenue of 65.32M with -3.42% growth.
- Revenue (ttm)
- 65.26M
- Revenue Growth
- -6.02%
- P/S Ratio
- 4.28
- Revenue/Employee
- EUR 544,367
- Employees
- 120
- Market Cap
- EUR 279.30M
Revenue Chart
Enanta Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 65.32M | -2.31M | -3.42% |
| Sep 30, 2024 | 67.64M | -11.57M | -14.61% |
| Sep 30, 2023 | 79.20M | -6.96M | -8.07% |
| Sep 30, 2022 | 86.16M | -10.91M | -11.24% |
| Sep 30, 2021 | 97.07M | -25.40M | -20.74% |
| Sep 30, 2020 | 122.47M | -82.72M | -40.31% |
| Sep 30, 2019 | 205.20M | -1.43M | -0.69% |
| Sep 30, 2018 | 206.63M | 103.81M | 100.97% |
| Sep 30, 2017 | 102.81M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.